🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Status
Recruiting
Location
EuroCityClinic LLC
Start Date
2025-08-14
Trial ID
NCT07130032
Treatments Being Tested
This is a first in human, open-label, multi-center Phase 1 / 2 study to eva...
Status
Recruiting
Location
Sylvester Comprehensive Cancer Center - Miami
Start Date
2022-04-04
Trial ID
NCT05267626
Treatments Being Tested
This is a Phase 2 study designed to evaluate the combination of checkpoint ...
Status
Completed
Location
University of Minnesota Masonic Cancer Center
Start Date
2019-05-28
Trial ID
NCT03850691
Modulating the gut microbiome to improve response to immune-checkpoint inhi...
Status
Completed
Location
CISSS de la Montérégie-Centre- Hôpital Charles-Le Moyne
Start Date
2022-06-29
Trial ID
NCT05303493
Treatments Being Tested
The Phase 2 study is a multicenter, open-label study of RP1 to further inve...
Status
Active Not Recruiting
Location
University of Birmingham Alabama
Start Date
2017-09-20
Trial ID
NCT03767348
The primary objectives of this study are to evaluate the safety and tolerab...
Status
Completed
Location
Liverpool Hospital
Start Date
2021-08-14
Trial ID
NCT04891770
Treatments Being Tested
Infection with Kaposi sarcoma herpesvirus (KSHV, or human herpesvirus-8 (HH...
Status
Completed
Location
Zuckerberg San Francisco General Hospital
Start Date
2018-05-07
Trial ID
NCT03316274
Treatments Being Tested
The goal of this observational study is to examine genetic changes that may...
Status
Withdrawn
Location
Duke University
Start Date
2025-04-16
Trial ID
NCT06283238
Treatments Being Tested